Multiplexed tandem polymerase chain reaction identifies strong expression of oestrogen receptor and Her-2 from single, formalin-fixed, paraffin-embedded breast cancer sections.
Thompson, Erik W; Warton, Kristina; Blick, Tony; Wafai, Razan; Hill, Prue; Stanley, Keith.
; 42(2): 165-72, 2010 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-20085519
A Genetic Tool to Track Protein Aggregates and Control Prion Inheritance.
An updated systematic review of the cost-effectiveness of therapies for metastatic breast cancer.
Cost-Effectiveness Analysis of Pertuzumab With Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Adjuvant Treatment of HER2-Positive Breast Cancer in the United States.
[Companion diagnostics in the era of personalized medicine--chairmen's introductory remarks].
Palbociclib as a first-line treatment in oestrogen receptor-positive, HER2-negative, advanced breast cancer not cost-effective with current pricing: a health economic analysis of the Swiss Group for Clinical Cancer Research (SAKK).
Modelling the cost-effectiveness of adjuvant lapatinib for early-stage breast cancer.
Multigene assays and molecular markers in breast cancer: systematic review of health economic analyses.
A decision impact, decision conflict and economic assessment of routine Oncotype DX testing of 146 women with node-negative or pNImi, ER-positive breast cancer in the U.K.
Cost-effectiveness analysis of 1st through 3rd line sequential targeted therapy in HER2-positive metastatic breast cancer in the United States.
Oleaginous yeasts for sustainable lipid production-from biodiesel to surf boards, a wide range of "green" applications.